Mesco Pharmaceuticals Ltd. announced unaudited earnings results for the first quarter ended June 30, 2017. For the quarter, the company reported loss before exceptional items and tax finance costs and exceptional items of INR 51,050.520 million against INR 7,496.8 million a year ago. Loss before tax and loss for the period was INR 51,050.520 million against INR 7,496.8 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.03 against INR 0.00 a year ago.